VioQuest 
Welcome,         Profile    Billing    Logout  
 2 Products   76 Diseases  2 Products   5 Trials   423 News 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triciribine phosphate (PTX-200) / VioQuest, Prescient Therap
NCT02930109: A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia

Hourglass Jul 2019 - Sep 2019 : From P1b portion of P1b/2 trial
Completed
1/2
33
US
PTX-200, Triciribine Phosphate Monohydrate, Cytarabine, Ara-C
Prescient Therapeutics, Ltd.
Acute Leukemia
10/23
03/24
Lenocta (sodium stibogluconate) / VioQuest
NCT05708625: Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis

Recruiting
3
136
RoW
Intralesional Sodium stibogluconate, SSG, Intralesional Cryotherapy, Intralesional Voriconazole, Vfend, Oral doxycycline
Zagazig University
Leishmaniasis, Cutaneous
12/23
03/24
NCT04906031: Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Recruiting
2
5
RoW
Sodium stibogluconate, SSG
First Affiliated Hospital of Jinan University, Ruijin Hospital
Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy, Temperature-Sensitive p53 Mutation, Sodium Stibogluconate, P53 Mutation
02/23
02/24
NCT05957978: LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Active, not recruiting
2
52
RoW
LXE408, sodium stibogluconate, Paromomycin
Drugs for Neglected Diseases, Novartis Pharmaceuticals
Primary Visceral Leishmaniasis
06/25
11/25
NCT06798402: Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Recruiting
2
80
RoW
Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam)
Al-Mustafa University College, Al-Mustansiriyah University
Cutaneous Leishmaniasis
05/25
05/25
NCT00508963: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

No Longer Available
N/A
US
sodium stibogluconate (Pentostam)
University of California, San Francisco
Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous
 
 
NCT04699383: Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia

Completed
N/A
105
RoW
Sodium Stibogluconate with allopurinol
Institute of Tropical Medicine, Belgium, Wollo University, Boru Meda Hospital, University of Gondar
Cutaneous Leishmaniasis
12/22
12/22
NCT04342715: A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Active, not recruiting
N/A
216
RoW
Sodium stibogluconate / paramomycin
University of York, University of Gondar, Kenya Medical Research Institute, Makerere University, University of Khartoum, European Vaccine Initiative, European and Developing Countries Clinical Trials Partnership (EDCTP)
Visceral Leishmaniasis
09/24
03/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triciribine phosphate (PTX-200) / VioQuest, Prescient Therap
NCT02930109: A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia

Hourglass Jul 2019 - Sep 2019 : From P1b portion of P1b/2 trial
Completed
1/2
33
US
PTX-200, Triciribine Phosphate Monohydrate, Cytarabine, Ara-C
Prescient Therapeutics, Ltd.
Acute Leukemia
10/23
03/24
Lenocta (sodium stibogluconate) / VioQuest
NCT05708625: Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis

Recruiting
3
136
RoW
Intralesional Sodium stibogluconate, SSG, Intralesional Cryotherapy, Intralesional Voriconazole, Vfend, Oral doxycycline
Zagazig University
Leishmaniasis, Cutaneous
12/23
03/24
NCT04906031: Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Recruiting
2
5
RoW
Sodium stibogluconate, SSG
First Affiliated Hospital of Jinan University, Ruijin Hospital
Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy, Temperature-Sensitive p53 Mutation, Sodium Stibogluconate, P53 Mutation
02/23
02/24
NCT05957978: LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Active, not recruiting
2
52
RoW
LXE408, sodium stibogluconate, Paromomycin
Drugs for Neglected Diseases, Novartis Pharmaceuticals
Primary Visceral Leishmaniasis
06/25
11/25
NCT06798402: Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Recruiting
2
80
RoW
Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam)
Al-Mustafa University College, Al-Mustansiriyah University
Cutaneous Leishmaniasis
05/25
05/25
NCT00508963: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

No Longer Available
N/A
US
sodium stibogluconate (Pentostam)
University of California, San Francisco
Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous
 
 
NCT04699383: Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia

Completed
N/A
105
RoW
Sodium Stibogluconate with allopurinol
Institute of Tropical Medicine, Belgium, Wollo University, Boru Meda Hospital, University of Gondar
Cutaneous Leishmaniasis
12/22
12/22
NCT04342715: A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Active, not recruiting
N/A
216
RoW
Sodium stibogluconate / paramomycin
University of York, University of Gondar, Kenya Medical Research Institute, Makerere University, University of Khartoum, European Vaccine Initiative, European and Developing Countries Clinical Trials Partnership (EDCTP)
Visceral Leishmaniasis
09/24
03/25

Download Options